Table 1 Summary characteristics of patients with at least one isolate typed by PFGE.
Demographics | ||
Age at first isolation in cohort (median, IQR) (years) | 23.02 (19.9–30.54) | |
Age at last sample (median, IQR) (years) | 27.64 (22.14–36.62) | |
Sex (% female) | 53.73 | |
CF Co-morbidities* | ||
F508del/F508 del (%) | 43.94 | |
F508del/other (%) | 36.36 | |
Pancreatic insufficient (%) | 75.76 | |
Chronic P. aeruginosa (%)** | 42.62 | |
Chronic S. aureus (%)** | 63.93 | |
CF-related diabetes (%) | 9.09 | |
CF-related liver disease (%) | 15.15 | |
Disease markers* | ||
FEV1 percent predicted (median, IQR) | 69.5 (50–87) | |
FVC percent predicted (median, IQR) | 89.5 (75–105) | |
Chronic supplemental oxygen requirements (%) | 6.06 | |
Enteral feeding receipt (%) | 7.58 | |
At first isolate | Any time | |
|---|---|---|
Chronic medications | ||
Inhaled Tobramycin (%) | 7.58 | 15.15 |
Azithromycin (%) | 7.58 | 15.15 |
TMP-SMX (%) | 4.55 | 7.81 |
Inhaled DNase (%) | 30.3 | 50 |
Inhaled HT Saline (%) | 19.4 | 29.85 |
